Funder: National Institutes of Health
Due Dates: October 1, 2025 (Advisory Council Review) | December 1, 2025 (Earliest Start Date)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period is 5 years.
Summary: Supports investigator-initiated, early-stage (Phase I/II), greater-than-minimal-risk clinical trials of interventions for vision disorders.
Key Information: A full clinical protocol, data management plan, and NEI staff involvement statement are required; contact NEI program staff before applying.